Claire Rogel-Gaillard

Title: Claire Rogel-Gaillard: Innovator in Energy Metabolism

Introduction

Claire Rogel-Gaillard is a prominent inventor based in Paris, France. She has made significant contributions to the field of energy metabolism through her innovative research and patents. Her work focuses on the gamma chain of AMP-activated kinase (AMPK), which plays a crucial role in cellular energy homeostasis.

Latest Patents

Claire holds a patent titled "Variants of the Gamma Chain of AMPX, DNA sequences encoding the same, and uses thereof." This patent encompasses variants of the gamma chain of vertebrate AMPK, as well as nucleic acid sequences encoding these variants. The applications of her patent are particularly relevant for the diagnosis and treatment of dysfunctions in energy metabolism. She has 1 patent to her name.

Career Highlights

Throughout her career, Claire has demonstrated a strong commitment to advancing scientific knowledge in her field. Her work has not only contributed to academic research but also has potential implications for therapeutic applications in medicine. She is currently associated with Arexis Ab, a company dedicated to innovative research and development.

Collaborations

Claire has collaborated with notable scientists, including Leif Andersson and Christian Looft. These partnerships have enriched her research and expanded the impact of her work in the scientific community.

Conclusion

Claire Rogel-Gaillard is a trailblazer in the field of energy metabolism, with her innovative patent paving the way for future research and applications. Her contributions are vital for understanding and addressing energy-related health issues.